Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT8 Antikörper

Dieser Maus Monoklonal Antikörper detektiert spezifisch KRT8 in IHC. Es zeigt Reaktivität gegenüber Proben von Human und Hund.
Produktnummer ABIN7863059
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für KRT8 Antikörper (ABIN7863059)

Target

Alle KRT8 Antikörper anzeigen
KRT8 (Keratin 8 (KRT8))

Reaktivität

  • 342
  • 92
  • 90
  • 69
  • 68
  • 66
  • 65
  • 16
  • 14
  • 10
  • 9
  • 7
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human, Hund

Wirt

  • 179
  • 175
  • 3
Maus

Klonalität

  • 215
  • 139
  • 1
Monoklonal

Konjugat

  • 199
  • 26
  • 17
  • 8
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser KRT8 Antikörper ist unkonjugiert

Applikation

  • 257
  • 186
  • 137
  • 105
  • 73
  • 56
  • 52
  • 41
  • 41
  • 39
  • 35
  • 25
  • 23
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC)

Klon

KRT8-4006
  • Verwendungszweck

    Cytokeratin 8 (KRT8) Antibody

    Spezifität

    Epitope of this MAb is located between aa343-357. Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ( ring-like, perinuclear ) from ductal ( peripheral-predominant ) carcinoma of the breast.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Keratin preparation from a human carcinoma

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    KRT8 (Keratin 8 (KRT8))

    Andere Bezeichnung

    Cytokeratin 8

    Hintergrund

    CARD2, CK8, CYK8, CYKER, Cytokeratin Endo A, DreK8, EndoA, K2C8, K8, Keratin 8, Krt 2.8, KRT8, Type-II Keratin Kb8

    Colon, HCT116, HeLa or A431 cells. Human skin, lung or breast carcinoma., MCF-7

    Molekulargewicht

    52.5kDa

    Gen-ID

    3856

    UniProt

    P05787
Sie sind hier:
Chat with us!